NCT00833612

Brief Summary

Subjects with anterior acute STEMI who receive an IABC before primary PCI will have decreased MI size.

Trial Health

98
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
339

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Dec 2008

Typical duration for phase_4

Geographic Reach
10 countries

40 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2008

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 27, 2009

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 2, 2009

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2011

Completed
Last Updated

June 27, 2011

Status Verified

June 1, 2011

Enrollment Period

2.2 years

First QC Date

January 27, 2009

Last Update Submit

June 24, 2011

Conditions

Keywords

IABCAMI

Outcome Measures

Primary Outcomes (1)

  • To determine whether IABC before mechanical reperfusion decreases myocardial infarct (MI) size.

    3-5 days

Secondary Outcomes (1)

  • To determine the effect of IABC before mechanical reperfusion on post PCI cardiovascular function and major adverse cardiac events (MACE) (ie, death, reinfarction, and CHF) at 30 days and 6 months.

    30 days and 6 months post randomization

Study Arms (1)

Control arm of study

NO INTERVENTION
Device: Counterpulsation with IAB

Interventions

IABC pre-reperfusion PCI

Also known as: CS100 & CS300 IAB Linear 7.5F Fidelity 8.0 F Sensation 7.0 F
Control arm of study

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to understand and sign an ICF
  • ≥ 18 and ≤ 90 years of age
  • General good health, in the opinion of the investigator
  • ST elevation of 2mm in 2 contiguous anterior leads or ≥ 4mm total in anterior leads
  • Scheduled for PCI \< 6 hours from onset of symptoms of MI

You may not qualify if:

  • Known contraindication to MRI
  • Prior thrombolytic therapy during the index event
  • Known history of MI
  • Known severe aortic insufficiency
  • Known aortic aneurysm
  • Known severe calcific aorta-iliac disease or peripheral vascular disease
  • Experiencing cardiac shock
  • Known end-stage renal disease
  • Weight \>400 lbs. or height \<4 ft.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (40)

University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

Location

University of Southern California

Los Angeles, California, 90033, United States

Location

Washington Hospital Center

Washington D.C., District of Columbia, 20010, United States

Location

Cleveland Clinic Florida

Weston, Florida, 33331, United States

Location

Tufts Medical Center

Boston, Massachusetts, 02111, United States

Location

Caritas St. Elizabeth's Medical Center

Boston, Massachusetts, 02135, United States

Location

Essentia Institute of Rural Health (St Mary's)

Duluth, Minnesota, 55805, United States

Location

University of Nebraska Medical Center

Omaha, Nebraska, 68198, United States

Location

University of Medicine and Dentistry of New Jersey

Newark, New Jersey, 07103, United States

Location

Newark Beth Israel Hospital

Newark, New Jersey, 07112, United States

Location

University of Rochester Medical Center-Strong Memorial Hospital

Rochester, New York, 14627, United States

Location

Duke University Medical Center

Durham, North Carolina, 27705, United States

Location

Lancaster General Hospital

Lancaster, Pennsylvania, 17603, United States

Location

Temple University Hospital

Philadelphia, Pennsylvania, 19140, United States

Location

Allegheny General Hospital

Pittsburgh, Pennsylvania, 15212, United States

Location

University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

Location

Flinders Medical Centre

Bedford Park, 5042, Australia

Location

Virga Jesse

Hasselt, 3500, Belgium

Location

Institut Hospitalier Jacques Cartier

Massy, Alsace, 91349, France

Location

Klinik fur Innere Medizin und Kardiologie

Dresden, 1307, Germany

Location

University of Freiburg

Freiburg im Breisgau, Germany

Location

Herzzentrum Leipzig GmbH

Leipzig, D-04289, Germany

Location

Gurunanak CARE Hospital

Hyderabad, Andhra Pradesh, 500020, India

Location

Baroda Heart Institute and Research Centre

Vadodara, Gujarat, 390 007, India

Location

Saint John's Medical College and Hospital

Bangalore, Karnataka, 560034, India

Location

Bhagwan Mahaveer Jain Heart Centre

Bangalore, 560052, India

Location

Apollo Hospitals

Bangalore, India

Location

Medanta - The Medicity

Delhi, 122 001, India

Location

CARE Hospital

Hyderabad, 50034, India

Location

Tagore Hospital and Heart Care Centre

Jalandhar, 144 008, India

Location

Indraprastha Apollo Hospital

New Delhi, 110044, India

Location

Sir Gangaram Hospital

New Delhi, 110060, India

Location

Apollo Gleneagles Hospital

West Bengal, India

Location

Mater Misericordiae University Hospital

Dublin, 7, Ireland

Location

Azienda Ospedaliero Universitaria Cargeei

Florence, 50141, Italy

Location

Catharina Hospital

Eindhoven, 2, Netherlands

Location

Royal Bournemouth Hospital

Dorset, BH7 7DW, United Kingdom

Location

Royal Infirmary of Edinburgh

Edinburgh, EH8 9RS, United Kingdom

Location

Leeds General Infirmary

Leeds, LS9 7TF, United Kingdom

Location

St. Thomas Hospital

London, SE1 7EH, United Kingdom

Location

Related Publications (2)

  • Patel MR, Smalling RW, Thiele H, Barnhart HX, Zhou Y, Chandra P, Chew D, Cohen M, French J, Perera D, Ohman EM. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA. 2011 Sep 28;306(12):1329-37. doi: 10.1001/jama.2011.1280. Epub 2011 Aug 29.

  • Patel MR, Thiele H, Smalling RW, Chandra P, Zhou Y, Cohen M, Perera D, Ohman EM. A multicenter, randomized, controlled study of mechanical left ventricular unloading with counterpulsation to reduce infarct size prepercutaneous coronary intervention for acute myocardial infarction: rationale and design of the Counterpulsation Reduces Infarct Size Acute Myocardial Infarction trial. Am Heart J. 2011 Jul;162(1):47-55.e1. doi: 10.1016/j.ahj.2011.03.037.

MeSH Terms

Interventions

Counterpulsation

Intervention Hierarchy (Ancestors)

Assisted CirculationSurgical Procedures, Operative

Study Officials

  • Magnus Ohman, MD

    Duke University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

January 27, 2009

First Posted

February 2, 2009

Study Start

December 1, 2008

Primary Completion

March 1, 2011

Study Completion

March 1, 2011

Last Updated

June 27, 2011

Record last verified: 2011-06

Locations